ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,809, issued on Nov. 11, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).
"CDK2/5 degraders and uses thereof" was invented by Nathanael Gray (Stanford, Calif.), Nicholas Kwiatkowski (Brookline, Mass.), Eric Fischer (Chestnut Hill, Mass.), Katherine Donovan (Boston), Tinghu Zhang (Brookline, Mass.), Mingxing Teng (Boston) and Jie Jiang (Brookline, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to bifunctional compounds, compositions, and methods for treating diseases or conditions mediated by dysfunctional cyclin-dependent kinase 2 (CDK2) and CDK5 activity."
The patent was filed on April 2, 2020, under A...